Brief: Natco Pharma Investing $14 Million In Egenesis Via Units
25/08/2026 08:32
BRIEF-Natco Pharma Investing $14 Million In Egenesis Via Units Aug 25 (Reuters) - Natco Pharma Ltd NATP.NS:
NATCO PHARMA - INVESTING $14 MILLION IN EGENESIS, INC VIA UNITS
Source text: [ID:]
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees